Hongbo Lu
Director at Arrowhead Pharmaceuticals, Inc. (ARWR); Director at Zenas BioPharma, Inc. (ZBIO)
Purchase track record
Below average. Based on 4 purchases with a full 90 days of price history.
24
Avg. 90-day return-1.9%
vs. S&P 500-12.3%
Beat the market50%
Paper profit on buys+$3.5M
Total bought / sold$8.2M / $228K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 14SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 2,97052,012 held (−5%) | $76.88 | $228K | -18.4% |
| Apr 2SEC | ZBIOZenas BioPharma, Inc. | Buy | 3,768426,736 held (+1%) | $18.63 | $70K | +46.3% |
| Mar 31SEC | ZBIOZenas BioPharma, Inc. | Buy | 75,000422,968 held (+22%) | $20.00 | $1.5M | +36.3% |
| Feb 13SEC | ZBIOZenas BioPharma, Inc. | Buy | 25,985347,968 held (+8%) | $22.50 | $585K | +21.2% |
| Oct 9SEC | ZBIOZenas BioPharma, Inc. | Buy | 58,823new position | $17.00 | $1000K | +60.4% |
| Oct 9SEC | ZBIOZenas BioPharma, Inc. | Buy | 263,160321,983 held (+447%) | $19.00 | $5.0M | +43.5% |
- Sell
Director Hongbo Lu sold $228K of ARWR at $76.88 — pre-scheduled 10b5-1 plan sale.
- Buy
Director Hongbo Lu bought $1.5M of ZBIO at $20.00 — raises the stake by 22%.
- Buy
Director Hongbo Lu bought $1000K of ZBIO at $17.00 — first open-market purchase in our records; opens a new position.
- Buy
Director Hongbo Lu bought $5.0M of ZBIO at $19.00 — largest purchase by this insider in our records; first purchase in 12 months; raises the stake by 447%.